卖什么
一次性内窥镜。
商业模式拆解
买家：谁掌握预算？
未核实Hospital procurement and department heads (urology, pulmonology, anesthesia, GI, ENT, gynecology) or local distributors.
触发点：什么让他们现在购买？
未核实Avoiding reprocessing cost and cross-infection risk of reusable endoscopes (inferred from single-use positioning).
工作流：什么输入变成什么输出？
Single-use ureteroscopes, bronchoscopes, cystoscopes, duodenoscopes and video laryngoscopes connect to HugeMed imaging processors, replacing reusable scope sterilization; plus disposable baskets, forceps and guidewires.
经济账：省了什么，怎么收费？
Per-procedure disposable scopes and consumables plus capital imaging processors and pumps (razor/blade); R&D is 25% of sales; capacity over 50,000 units monthly.
渠道：怎么接触到客户？
Direct sales network plus local distributors in over 100 countries; NMPA, CE MDR, FDA 510(k), MDSAP, ISO 13485; 10,000+ hospitals claimed.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-03-30 | C+ 轮 | — | — | news.pedaily.cn |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.